Extended-spectrum β-lactamases: Structure and kinetic mechanism

Clinical Microbiology and Infection

Volumn 14, Issue SUPPL. 1, 2008, Pages 63-74

  Page, Malcolm G P ^a  

^a BASILEA PHARMACEUTICA INTERNATIONAL LTD   (Switzerland)

Author keywords

Conformation change; ESBL; Kinetics; Review; lactamase; lactamase inhibitior

Indexed keywords

AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFALORIDINE; CEFALOTIN; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE; GLUTAMIC ACID; GLYCINE; HISTIDINE; IMIPENEM; ISOLEUCINE; LEUCINE; LYSINE; METHIONINE; PENICILLIN G; SERINE; SULBACTAM; THREONINE; VALINE;

AMINO ACID SUBSTITUTION; CONFORMATIONAL TRANSITION; DRUG HYDROLYSIS; DRUG STRUCTURE; ENZYME KINETICS; ENZYME SPECIFICITY; ENZYME STRUCTURE; GENE MUTATION; GRAM NEGATIVE BACTERIUM; INFRARED SPECTROSCOPY; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; REVIEW; STEADY STATE; X RAY CRYSTALLOGRAPHY;

EID: 37249085038     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2007.01863.x     Document Type: Review

References (27)

1. Pratt RF. β-Lactamase: Inhibition. In: Page MI, ed., The chemistry of β-lactams, 1st edn. London: Blackie Academic & Professional, 1992; 229-271.
2. Waley SG. β-Lactamase: Mechanism of action. In: Page MI, ed., The chemistry of β-lactams, 1st edn. London: Blackie Academic & Professional, 1992; 198-228.
3. Wharton CW, Page MGP, Chittock RS, Regan TE, Ward S. Infrared spectroscopy of enzyme reaction intermediates. Laser Chem 1999; 19: 209-222.
4. Knox JR. Extended-spectrum and inhibitor-resistant TEM-type β-lactamases: Mutations, specificity, and three-dimensional structure. Antimicrob Agents Chemother 1995; 39: 2593-2601.
5. Wang X, Minasov G, Shoichet BK. The structural bases of antibiotic resistance in the clinically derived mutant β-lactamases TEM-30, TEM-32 and TEM-34. J Biol Chem 2002; 277: 32149-32156.
6. Wang X, Minasov G, Shoichet BK. Evolution of an antibiotic resistance enzyme constrained by stability and activity trade-offs. J Mol Biol 2002; 320: 85-95.
7. Savard P-Y, Gagne SM. Backbone dynamics of TEM-1 determined by NMR: evidence for a highly ordered protein. Biochemistry 2006; 45: 11414-11424.
8. Page MGP. The kinetics of non-stoichiometric bursts of β-lactam hydrolysis catalyzed by classC β-lactamases. Biochem J 1993; 295: 295-304.
9. Cohen SA, Pratt RF. Inactivation of Bacillus cereus beta-lactamaseI by 6 beta-bromopencillanic acid: Mechanism. Biochemistry 1980; 19: 3996-4003.
10. Faraci WS, Pratt RF. Elimination of a good leaving group from the 3′-position of a cephalosporin need not be concerted with β-lactam ring opening: TEM-2 β-lactamase-catalyzed hydrolysis of pyridine-2-azo-4′-(N ′, N ′-dimethylaniline) cephalosporin (PADAC) and of cephaloridine. J Am Chem Soc 1984; 106: 1489-1490.
11. Faraci WS, Pratt RF. Mechanism of inhibition of the PC1 β- lactamase of Staphylococcus aureus by cephalosporins: Importance of the 3′ leaving group. Biochemistry 1985; 24: 903-910.
12. Raquet X, Vanhove M, Lamotte-Brasseur J, Goussard S, Courvalin P, Frère JM. Stability of TEM beta-lactamase mutants hydrolyzing third generation cephalosporins. Proteins Struct Funct Genet 1995; 23: 63-72.
13. Bethel CR, Hujer AM, Hujer KM et al. Role of Asp104 in the SHV β-lactamase. Antimicrob Agents Chemother 2006; 50: 4124-4131.
14. Sideraki V, Huang W, Palzkill T, Gilbert HF. A secondary drug resistance mutation of TEM-1 beta-lactamase that suppresses misfolding and aggregation. Proc Natl Acad Sci USA 2000; 98: 283-288.
15. Pasquali F, Kehrenberg C, Manfreda G, Schwarz S. Physical linkage of Tn3 and part of Tn1721 in a tetracycline and ampicillin resistance plasmid from Salmonella typhimurium. J Antimicrob Chemother 2005; 55: 562-565.
16. Huang W, Palzkill T. A natural polymorphism in beta-lactamase is a global suppressor. Proc Natl Acad Sci USA 1997; 94: 8801-8806.
17. Perilli M, Segatore B, Rosaria de Massis M et al. TEM-t2, a new extended-spectrum β-lactamase detected in Proteus mirabilis and Morganella morganii in Italy. Antimicrob Agents Chemother 2000; 44: 2537-2539.
18. Nukaga M, Mayama K, Hujer AM, Bonomo RA, Knox JR. Ultrahigh resolution structure of a classA β-lactamase: On the mechanism and specificity of the extended-spectrum SHV-2 enzyme. J Mol Biol 2003; 328: 289-301.
19. Orencia MC, Yoon JS, Ness JE, Stemmer WP, Stevens RC. Predicting the emergence of antibiotic resistance by directed evolution and structural analysis. Nat Struct Biol 2001; 8: 238-242.
20. Bonomo RA, Dawes CG, Knox JR, Shlaes DM. β-Lactamase mutations far from the active site influence inhibitor binding. Biochim Biophys Acta Prot Struct Mol Enzymol 1995; 1247: 121-125.
21. Robin F, Delmas J, Chanal C, Sirot D, Sirot J, Bonnet R. TEM-109 (CMT-5), a natural complex mutant of TEM-1 β-lactamase combining the amino acid substitutions of TEM-6 and TEM-33 (IRT-5). Antimicrob Agents Chemother 2005; 49: 4443-4447.
22. Petit A, Maveyraud L, Lenfant F, Samama J-P, Labia R, Masson J-M. Multiple substitutions at position104 of β-lactamase TEM-1: assessing the role of this residue in substrate specificity. Biochem J 1995; 305: 33-40.
23. Raquet X, Lamotte-Brasseur X, Fonzé E, Goussard S, Courvalin P, Frère JM. TEM β-lactamase mutants hydrolyzing third-generation cephalosporins. A kinetic and modelling analysis. J Mol Biol 1994; 244: 625-639.
24. Chanal-Claris C, Sirot D, Bret L, Chatron P, Labia R, Sirot J. Novel extended-spectrum TEM-type β-lactamase from an Escherichia coli isolate resistant to ceftazidime and susceptible to cephalothin. Antimicrob Agents Chemother 1997; 41: 715-716.
25. Lee K-Y, Hopkins JD, O'Brien TF, Syvanen M. Gly238Ser substitution changes the substrate specificity of the SHV classA β-lactamases. Proteins Struct Funct Genet 1991; 11: 45-51.
26. Queenan AM, Foleno B, Gownley C, Wira E, Bush K. Effects of inoculum and β-lactamase activity in AmpC- and extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology. J Clin Microbiol 2004; 42: 269-275.
27. Poirel L, Mammeri H, Nordmann P. TEM-121, a novel complex mutant of TEM-type β-lactamase from Enterobacter aerogenes. Antimicrob Agents Chemother 2004; 48: 4528-4531.